Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1990 Jun;136(6):1223–1228.

Amyloid in familial amyloidosis, Finnish type, is antigenically and structurally related to gelsolin.

M Haltia 1, J Ghiso 1, F Prelli 1, G Gallo 1, S Kiuru 1, H Somer 1, J Palo 1, B Frangione 1
PMCID: PMC1877581  PMID: 2162627

Abstract

Immunohistochemical studies of six patients with familial amyloidosis, Finnish type, showed that their amyloid deposits did not react with polyclonal antibodies against the amyloid proteins of other, established forms of systemic or cerebral amyloidosis. However, strong immunoreactivity was observed with rabbit antiserum raised against a low molecular weight purified amyloid subunit isolated from one of the patients. This immunoreactivity was abolished by absorption with the low molecular weight amyloid fraction. The amino terminal sequence of the amyloid protein subunit was homologous to gelsolin, an actin-modulating protein, and the amyloid deposits in tissues reacted with a monoclonal antibody against gelsolin. These studies show that the amyloid protein in familial amyloidosis, Finnish type, is not related to previously identified forms of amyloid, including prealbumin (transthyretin) variants, but represents a novel amyloidogenic protein related to gelsolin, a plasma and cytoplasmic protein.

Full text

PDF
1223

Images in this article

1225Figure 1
on p.1225
1225Figure 2
on p.1225
1226Figure 3
on p.1226

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boysen G., Galassi G., Kamieniecka Z., Schlaeger J., Trojaborg W. Familial amyloidosis with cranial neuropathy and corneal lattice dystrophy. J Neurol Neurosurg Psychiatry. 1979 Nov;42(11):1020–1030. doi: 10.1136/jnnp.42.11.1020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Castaño E. M., Ghiso J., Prelli F., Gorevic P. D., Migheli A., Frangione B. In vitro formation of amyloid fibrils from two synthetic peptides of different lengths homologous to Alzheimer's disease beta-protein. Biochem Biophys Res Commun. 1986 Dec 15;141(2):782–789. doi: 10.1016/s0006-291x(86)80241-8. [DOI] [PubMed] [Google Scholar]
  3. Coria F., Castaño E., Prelli F., Larrondo-Lillo M., van Duinen S., Shelanski M. L., Frangione B. Isolation and characterization of amyloid P component from Alzheimer's disease and other types of cerebral amyloidosis. Lab Invest. 1988 Apr;58(4):454–458. [PubMed] [Google Scholar]
  4. Darras B. T., Adelman L. S., Mora J. S., Bodziner R. A., Munsat T. L. Familial amyloidosis with cranial neuropathy and corneal lattice dystrophy. Neurology. 1986 Mar;36(3):432–435. doi: 10.1212/wnl.36.3.432. [DOI] [PubMed] [Google Scholar]
  5. Dyck R. F., Lockwood C. M., Kershaw M., McHugh N., Duance V. C., Baltz M. L., Pepys M. B. Amyloid P-component is a constituent of normal human glomerular basement membrane. J Exp Med. 1980 Nov 1;152(5):1162–1174. doi: 10.1084/jem.152.5.1162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ghiso J., Jensson O., Frangione B. Amyloid fibrils in hereditary cerebral hemorrhage with amyloidosis of Icelandic type is a variant of gamma-trace basic protein (cystatin C). Proc Natl Acad Sci U S A. 1986 May;83(9):2974–2978. doi: 10.1073/pnas.83.9.2974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Glenner G. G., Wong C. W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun. 1984 May 16;120(3):885–890. doi: 10.1016/s0006-291x(84)80190-4. [DOI] [PubMed] [Google Scholar]
  8. Gorevic P. D., Goñi F., Pons-Estel B., Alvarez F., Peress N. S., Frangione B. Isolation and partial characterization of neurofibrillary tangles and amyloid plaque core in Alzheimer's disease: immunohistological studies. J Neuropathol Exp Neurol. 1986 Nov;45(6):647–664. doi: 10.1097/00005072-198611000-00004. [DOI] [PubMed] [Google Scholar]
  9. Haltia M., Prelli F., Ghiso J., Kiuru S., Somer H., Palo J., Frangione B. Amyloid protein in familial amyloidosis (Finnish type) is homologous to gelsolin, an actin-binding protein. Biochem Biophys Res Commun. 1990 Mar 30;167(3):927–932. doi: 10.1016/0006-291x(90)90612-q. [DOI] [PubMed] [Google Scholar]
  10. Kwiatkowski D. J., Mehl R., Yin H. L. Genomic organization and biosynthesis of secreted and cytoplasmic forms of gelsolin. J Cell Biol. 1988 Feb;106(2):375–384. doi: 10.1083/jcb.106.2.375. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kwiatkowski D. J., Stossel T. P., Orkin S. H., Mole J. E., Colten H. R., Yin H. L. Plasma and cytoplasmic gelsolins are encoded by a single gene and contain a duplicated actin-binding domain. Nature. 1986 Oct 2;323(6087):455–458. doi: 10.1038/323455a0. [DOI] [PubMed] [Google Scholar]
  12. Kwiatkowski D. J., Westbrook C. A., Bruns G. A., Morton C. C. Localization of gelsolin proximal to ABL on chromosome 9. Am J Hum Genet. 1988 Apr;42(4):565–572. [PMC free article] [PubMed] [Google Scholar]
  13. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  14. Maury C. P., Alli K., Baumann M. Finnish hereditary amyloidosis. Amino acid sequence homology between the amyloid fibril protein and human plasma gelsoline. FEBS Lett. 1990 Jan 15;260(1):85–87. doi: 10.1016/0014-5793(90)80072-q. [DOI] [PubMed] [Google Scholar]
  15. Maury C. P., Teppo A. M., Karinemi A. L., Koeppen A. H. Amyloid fibril protein in familial amyloidosis with cranial neuropathy and corneal lattice dystrophy (FAP type IV) is related to transthyretin. Am J Clin Pathol. 1988 Mar;89(3):359–364. doi: 10.1093/ajcp/89.3.359. [DOI] [PubMed] [Google Scholar]
  16. Meretoja J. Comparative histopathological and clinical findings in eyes with lattice corneal dystrophy of two different types. Ophthalmologica. 1972;165(1):15–37. doi: 10.1159/000308469. [DOI] [PubMed] [Google Scholar]
  17. Meretoja J. Familial systemic paramyloidosis with lattice dystrophy of the cornea, progressive cranial neuropathy, skin changes and various internal symptoms. A previously unrecognized heritable syndrome. Ann Clin Res. 1969 Dec;1(4):314–324. [PubMed] [Google Scholar]
  18. Meretoja J. Genetic aspects of familial amyloidosis with corneal lattice dystrophy and cranial neuropathy. Clin Genet. 1973;4(3):173–185. doi: 10.1111/j.1399-0004.1973.tb01140.x. [DOI] [PubMed] [Google Scholar]
  19. Meretoja J., Hollmén T., Meretoja T., Penttinen R. Partial characterization of amyloid proteins in inherited amyloidosis with lattice corneal dystrophy and in secondary amyloidosis. Med Biol. 1978 Feb;56(1):17–22. [PubMed] [Google Scholar]
  20. Meretoja J., Jokinen E. J., Collan Y., Lähdevirta J. Renal biopsy findings in familial amyloidosis with corneal lattice dystrophy. An immuno-histochemical, light-microscopical and electron-microscopical study. Acta Pathol Microbiol Scand Suppl. 1972;233:228–238. [PubMed] [Google Scholar]
  21. Meretoja J., Teppo L. Histopathological findings of familial amyloidosis with cranial neuropathy as principal manifestation. Report on three cases. Acta Pathol Microbiol Scand A. 1971;79(5):432–440. doi: 10.1111/j.1699-0463.1971.tb01841.x. [DOI] [PubMed] [Google Scholar]
  22. Pepys M. B., Dyck R. F., de Beer F. C., Skinner M., Cohen A. S. Binding of serum amyloid P-component (SAP) by amyloid fibrils. Clin Exp Immunol. 1979 Nov;38(2):284–293. [PMC free article] [PubMed] [Google Scholar]
  23. Pras M., Prelli F., Franklin E. C., Frangione B. Primary structure of an amyloid prealbumin variant in familial polyneuropathy of Jewish origin. Proc Natl Acad Sci U S A. 1983 Jan;80(2):539–542. doi: 10.1073/pnas.80.2.539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Pras M., Schubert M., Zucker-Franklin D., Rimon A., Franklin E. C. The characterization of soluble amyloid prepared in water. J Clin Invest. 1968 Apr;47(4):924–933. doi: 10.1172/JCI105784. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Pras M., Zucker-Franklin D., Rimon A., Franklin E. C. Physical, chemical, and ultrastructural studies of water-soluble human amyloid fibrils. Comparative analyses of nine amyloid preparations. J Exp Med. 1969 Oct 1;130(4):777–796. doi: 10.1084/jem.130.4.777. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Prelli F., Pras M., Frangione B. Degradation and deposition of amyloid AA fibrils are tissue specific. Biochemistry. 1987 Dec 15;26(25):8251–8256. doi: 10.1021/bi00399a035. [DOI] [PubMed] [Google Scholar]
  27. Purcell J. J., Jr, Rodrigues M., Chishti M. I., Riner R. N., Dooley J. M. Lattice corneal dystrophy associated with familial systemic amyloidosis (Meretoja's syndrome). Ophthalmology. 1983 Dec;90(12):1512–1517. doi: 10.1016/s0161-6420(83)34369-4. [DOI] [PubMed] [Google Scholar]
  28. Rostagno A., Frangione B., Pearlstein E., Garcia-Pardo A. Fibronectin binds to amyloid P component. Localization of the binding site to the 31,000 dalton C-terminal domain. Biochem Biophys Res Commun. 1986 Oct 15;140(1):12–20. doi: 10.1016/0006-291x(86)91051-x. [DOI] [PubMed] [Google Scholar]
  29. Sack G. H., Jr, Dumars K. W., Gummerson K. S., Law A., McKusick V. A. Three forms of dominant amyloid neuropathy. Johns Hopkins Med J. 1981 Dec;149(6):239–247. [PubMed] [Google Scholar]
  30. Stossel T. P., Chaponnier C., Ezzell R. M., Hartwig J. H., Janmey P. A., Kwiatkowski D. J., Lind S. E., Smith D. B., Southwick F. S., Yin H. L. Nonmuscle actin-binding proteins. Annu Rev Cell Biol. 1985;1:353–402. doi: 10.1146/annurev.cb.01.110185.002033. [DOI] [PubMed] [Google Scholar]
  31. Winkelman J. E., Delleman J. W., Ansink B. J. Ein hereditäres Syndrom, bestehend aus peripherer Polyneuopatie, Hauveränderungen und gittriger Dystrophie der Hornhaut. Klin Monbl Augenheilkd. 1971 Nov;159(5):618–623. [PubMed] [Google Scholar]
  32. Yin H. L., Kwiatkowski D. J., Mole J. E., Cole F. S. Structure and biosynthesis of cytoplasmic and secreted variants of gelsolin. J Biol Chem. 1984 Apr 25;259(8):5271–5276. [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES